Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,795
Closed -$915K 172
2019
Q4
$915K Sell
3,795
-1,360
-26% -$300K 0.09% 148
2019
Q3
$998K Buy
+5,155
New +$989K 0.1% 120
2018
Q4
Sell
-31,117
Closed -$6.45M 342
2018
Q3
$6.45M Buy
31,117
+22,362
+255% +$4.41M 0.33% 69
2018
Q2
$1.62M Buy
+8,755
New +$1.55M 0.08% 182
2018
Q1
Sell
-27,104
Closed -$4.71M 281
2017
Q4
$4.71M Buy
27,104
+23,637
+682% +$4.18M 0.42% 42
2017
Q3
$646K Buy
+3,467
New +$614K 0.11% 74

Other funds holding AMGN

Kepos Capital's AMGN Position: Q1 2020 in Review

Kepos Capital sold out of Amgen (AMGN) in Q1 2020, closing a stake of 3,795 shares — an estimated $915K sold.

Kepos Capital first reported a position in AMGN in Q3 2017 and held it in 6 quarters. The position peaked at $6.45M in Q3 2018. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Kepos Capital reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 3,795 Amgen shares in Q1 2020, an estimated $915K.
  • Kepos Capital first reported a position in Amgen in Q3 2017 and held it in 6 quarters.
  • Kepos Capital's Amgen position peaked at $6.45M in Q3 2018.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.